Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ketoconazole

« Back to Dashboard

Summary for Generic Name: ketoconazole

Tradenames:6
Patents:6
Applicants:16
NDAs:21
Drug Master File Entries: see list15
Suppliers: see list6
Therapeutic Class:Antifungals

Pharmacology for Ingredient: ketoconazole

Clinical Trials for: ketoconazole

Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.
Status: Completed Condition: Asthma,; Pharmacokinetics,; Cmax,; Tmax,; λz,; AUC,; Ketoconazole,; Metabolite

Ketoconazole Foam 2% for the Treatment of Versicolor
Status: Completed Condition: Tinea Versicolor

Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
Status: Active, not recruiting Condition: Prostate Cancer

Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects
Status: Completed Condition: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Ketoconazole; Healthy Adult Volunteers

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
Status: Completed Condition: Cancer

Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole
Status: Completed Condition: Healthy

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole
Status: Completed Condition: Healthy

Ketoconazole and Dexamethasone in Prostate Cancer
Status: Active, not recruiting Condition: Prostate Cancer

Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex
Status: Completed Condition: Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor.

Drug-drug Interaction Study (CKD-501, Ketoconazole)
Status: Completed Condition: Type 2 Diabetes Mellitus

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Israel
KETOCONAZOLE
ketoconazole
AEROSOL, FOAM;TOPICAL091550Aug 25, 2011RXNo<disabled><disabled>
Teva
KETOCONAZOLE
ketoconazole
TABLET;ORAL075273Jun 15, 1999RXNo<disabled><disabled>
Mcneil Cons
NIZORAL A-D
ketoconazole
SHAMPOO;TOPICAL020310Oct 10, 1997OTCYes5,456,851<disabled><disabled>
Teva
KETOCONAZOLE
ketoconazole
TABLET;ORAL074971Jun 15, 1999DISCNNo<disabled><disabled>
Apotex
KETOCONAZOLE
ketoconazole
TABLET;ORAL075912Jan 10, 2002RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc